Dose escalation study with rhenium-188 hydroxyethylidene diphosphonate in prostate cancer patients with osseous metastases

被引：0
|
作者：
Palmedo, Holger [1 ]
Guhlke, Stefan [1 ]
Bender, Hans [1 ]
Sartor, Johannes [1 ]
Schoeneich, Georg [2 ]
Risse, Jörn [1 ]
Grünwald, Frank [1 ]
Knapp Jr., F.F. [3 ]
Biersack, Hans-Jürgen [1 ]
机构：
[1] Department of Nuclear Medicine, University of Bonn, Sigmund-Freud-Strasse 25, D-53127 Bonn, Germany
[2] Department of Urology, University of Bonn, Germany
[3] Nuclear Medicine Group, Oak Ridge National Laboratory, (ORNL), Oak Ridge, TN, United States
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2000年 / 27卷 / 02期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Grading
引用
收藏
页码：123 / 130
相关论文
共 50 条
  • [1] Dose escalation study with rhenium-188 hydroxyethylidene diphosphonate in prostate cancer patients with osseous metastases
    Holger Palmedo
    Stefan Guhlke
    Hans Bender
    Johannes Sartor
    Georg Schoeneich
    Jörn Risse
    Frank Grünwald
    F.F. [Russ] Knapp Jr.
    Hans-Jürgen Biersack
    European Journal of Nuclear Medicine, 2000, 27 : 123 - 130
  • [2] Dose escalation study with rhenium-188 hydroxyethylidene diphosphonate in prostate cancer patients with osseous metastases
    Palmedo, H
    Guhlke, S
    Bender, H
    Sartor, J
    Schoeneich, G
    Risse, J
    Grünwald, F
    Knapp, FF
    Biersack, HJ
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2000, 27 (02) : 123 - 130
  • [3] The Tolerance and Therapeutic Efficacy of Rhenium-188 Hydroxyethylidene Diphosphonate in Advanced Cancer Patients with Painful Osseous Metastases
    Cheng, Aiping
    Chen, Shaoliang
    Zhang, Ying
    Yin, Duanzhi
    Dong, Mengjie
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2011, 26 (02) : 237 - 244
  • [4] Pain palliation with rhenium-188 HEDP in prostate cancer patients with osseous metastases.
    Palmedo, H
    Bender, H
    Risse, J
    Guhlke, S
    Schoeneich, G
    Grünwald, F
    Knapp, FF
    Biersack, HJ
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (09): : 1211 - 1211
  • [5] Treatment of metastatic bone pain with rhenium-188 hydroxyethylidene diphosphonate
    Chen, SL
    Xu, KP
    Liu, WG
    Yao, ZF
    Chen, KJ
    Yin, DZ
    Wang, YX
    MEDICAL PRINCIPLES AND PRACTICE, 2001, 10 (02) : 98 - 101
  • [6] Effect of reaction conditions on preparations of Rhenium-188 hydroxyethylidene diphosphonate complexes
    Lin, WY
    Hsieh, JF
    Lin, CP
    Hsieh, BT
    Ting, G
    Wang, SJ
    Knapp, FF
    NUCLEAR MEDICINE AND BIOLOGY, 1999, 26 (04) : 455 - 459
  • [7] Dose escalation study with Re-188HEDP in prostate cancer patients with osseous metastases.
    Palmedo, H
    Guhlke, S
    Bender, H
    Sartor, J
    Schoeneich, G
    Risse, J
    Gruenwald, F
    Knapp, FF
    Biersack, HJ
    JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (05) : 218P - 218P
  • [8] Rhenium-188(Sn)HEDP for treatment of osseous metastases
    Maxon, HR
    Schroder, LE
    Washburn, LC
    Thomas, SR
    Samaratunga, RC
    Biniakiewicz, D
    Moulton, JS
    Cummings, D
    Ehrhardt, GJ
    Morris, V
    JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (04) : 659 - 663
  • [9] Rhenium-188 hydroxyethylidene diphosphonate: A new generator-produced radiotherapeutic drug of potential value for the treatment of bone metastases
    Lin, WY
    Lin, CP
    Yeh, SJ
    Hsieh, BT
    Tsai, ZT
    Ting, G
    Yen, ZC
    Wang, SJ
    Knapp, FF
    Stabin, MF
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1997, 24 (06) : 590 - 595
  • [10] Rhenium-188 hydroxyethylidene diphosphonate: a new generator-produced radiotherapeutic drug of potential value for the treatment of bone metastases
    Wan-Yu Lin
    Chih-Phoon Lin
    Si-Jung Yeh
    Bor-Tsung Hsieh
    Zei-Tsan Tsai
    Gann Ting
    Tzu-Chen Yen
    Shyh-Jen Wang
    Furn F. Knapp
    Michael G. Stabin
    European Journal of Nuclear Medicine, 1997, 24 : 590 - 595
12345